deltatrials
Completed PHASE2 INTERVENTIONAL 3-arm NCT05882812

Sustained Acoustic Medicine (SAM) for Symptomatic Treatment of Knee Pain Related to Osteoarthritis

Sponsor: ZetrOZ, Inc.

Conditions Arthritis Osteo Arthritis Knee
Interventions 2.5% Diclofenac Patches Sustained Acoustic Device with 0% Diclofenac Patch Sustained Acoustic Device with 2.5% Diclofenac Patch
Updated 6 times since 2023 Last updated: Apr 30, 2025 Started: Jun 3, 2023 Primary completion: Dec 31, 2023 Completion: Feb 22, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Arthritis and Osteo Arthritis Knee, this trial is completed. The trial is conducted by ZetrOZ, Inc. and has accumulated 6 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jun 2023 – ~Jul 2023 · 30 days · monthly snapshot~Jul 2023 – ~Mar 2024 · 8 months · monthly snapshotRecruiting~Mar 2024 – ~Jul 2024 · 4 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Jun 2025 · 9 months · monthly snapshotCompleted~Jun 2025 – present · 13 months · monthly snapshotCompleted

Change History

6 versions recorded

  1. Jun 2025 — Present [monthly]

    Completed PHASE2

  2. Sep 2024 — Jun 2025 [monthly]

    Completed PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  4. Mar 2024 — Jul 2024 [monthly]

    Completed PHASE2

    Status: Recruiting → Completed

  5. Jul 2023 — Mar 2024 [monthly]

    Recruiting PHASE2

▶ Show 1 earlier version

  1. Jun 2023 — Jul 2023 [monthly]

    Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • ZetrOZ, Inc.
Data source: ZetrOZ, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations